Oldenlandia diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1‐mediated p53 activation
暂无分享,去创建一个
C. Giordano | L. Gelsomino | I. Barone | S. Catalano | S. Andò | D. Bonofiglio | G. Statti | F. Menichini | G. Gu | Sebastiano Andò | Giancarlo Statti | Guowei Gu | Ines Barone | Luca Gelsomino | Cinzia Giordano | Daniela Bonofiglio | Francesco Menichini | Stefania Catalano
[1] Shishir Shishodia,et al. Molecular targets of dietary agents for prevention and therapy of cancer. , 2006, Biochemical pharmacology.
[2] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[3] S. Andò,et al. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation. , 2007, Cancer research.
[4] Jian Yu,et al. The transcriptional targets of p53 in apoptosis control. , 2005, Biochemical and biophysical research communications.
[5] S. Catalano,et al. 17β-Estradiol enhances α5 integrin subunit gene expression through ERα–Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells , 2010, Breast Cancer Research and Treatment.
[6] L. Novotný,et al. Dual activity of triterpenoids: apoptotic versus antidifferentiation effects , 2006, Archives of Toxicology.
[7] S. Willimott,et al. Apoptotic effect of Oldenlandia diffusa on the leukaemic cell line HL60 and human lymphocytes. , 2007, Journal of ethnopharmacology.
[8] Jun Shao,et al. Anticancer Activities of Oldenlandia diffusa , 2004, Journal of herbal pharmacotherapy.
[9] Hwan-Suck Chung,et al. Induction of nitric oxide synthase by Oldenlandia diffusa in mouse peritoneal macrophages. , 2002, Biological & pharmaceutical bulletin.
[10] K. Bhoola,et al. Natural products for cancer prevention: a global perspective. , 2003, Pharmacology & therapeutics.
[11] B. Shan,et al. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. , 1997, International journal of immunopharmacology.
[12] Rachel Schiff,et al. Estrogen-receptor biology: continuing progress and therapeutic implications. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Lacaille‐Dubois,et al. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents. , 2003, Mini reviews in medicinal chemistry.
[14] Zhong-Zhen Zhao,et al. Determination of iridoid glucosides for quality assessment of Herba Oldenlandiae by high-performance liquid chromatography. , 2006, Chemical & pharmaceutical bulletin.
[15] Bohdan Wasylyk,et al. Physiological and Pathological Consequences of the Interactions of the p53 Tumor Suppressor with the Glucocorticoid, Androgen, and Estrogen Receptors , 2004, Annals of the New York Academy of Sciences.
[16] S. Safe,et al. Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of a nuclear factor kappaB/CCAAT-binding transcription factor-1 complex. , 2002, Molecular endocrinology.
[17] J Liu,et al. Pharmacology of oleanolic acid and ursolic acid. , 1995, Journal of ethnopharmacology.
[18] D. Green,et al. Mechanisms of p53-dependent apoptosis. , 2001, Biochemical Society transactions.
[19] S. Fuqua,et al. Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling , 2010, Clinical Cancer Research.
[20] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[21] B. Katzenellenbogen,et al. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[22] S. Singletary,et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] S. Safe,et al. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. , 1994, The Journal of biological chemistry.
[24] Michael Berger,et al. Apoptosis - the p53 network , 2003, Journal of Cell Science.
[25] Zhong-Zhen Zhao,et al. Oleanolic acid isolated from Oldenlandia diffusa exhibits a unique growth inhibitory effect against ras-transformed fibroblasts. , 2009, Life sciences.
[26] M. Spiliotaki,et al. Ursolic Acid Triggers Apoptosis and Bcl-2 Downregulation in MCF-7 Breast Cancer Cells , 2009, Cancer investigation.
[27] Benita S Katzenellenbogen,et al. Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer , 2000, Breast Cancer Research.
[28] L. Novotný,et al. Ursolic acid: an anti-tumorigenic and chemopreventive activity. Minireview. , 2001, Neoplasma.
[29] M. Oren,et al. Regulation of p53 , 2002, Annals of the New York Academy of Sciences.
[30] A. Vachálková,et al. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. , 2004, Neoplasma.
[31] Moshe Oren,et al. Regulation of p53: intricate loops and delicate balances. , 2002, Annals of the New York Academy of Sciences.
[32] A. Giordano,et al. Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. , 2005, Endocrine-related cancer.
[33] R. Nicholson,et al. Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. , 2003, Endocrinology.
[34] S. Safe,et al. Functional synergy between the transcription factor Sp1 and the estrogen receptor. , 1997, Molecular endocrinology.
[35] S. Yamashita,et al. Aggregated Ursolic Acid, a Natural Triterpenoid, Induces IL-1β Release from Murine Peritoneal Macrophages: Role of CD361 , 2007, The Journal of Immunology.
[36] C. Giordano,et al. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation , 2009, Journal of cellular physiology.
[37] S. Fuqua,et al. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. , 2009, The American journal of pathology.
[38] J. Li,et al. Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15. , 2002, World journal of gastroenterology.
[39] S. Kane,et al. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells , 2002, Cancer Chemotherapy and Pharmacology.
[40] G. Yen,et al. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. , 2010, Molecular nutrition & food research.